Focused Niche Solutions
Gastrointestinal tract infections continue to be a significant public health issue across many regions of the world, including India. In recent years, a noticeable shift in disease patterns has emerged across Asia, where conditions traditionally associated with Western and high-income countries—such as Japan and South Korea—are now increasingly diagnosed in India. Gastrointestinal disorders, in particular, have shown a marked rise in prevalence.
This growing burden of GI diseases is closely associated with environmental and lifestyle changes driven by rapid industrialization, evolving dietary habits, improved sanitation practices, and widespread antibiotic usage. As a result, conditions such as gastroesophageal reflux disease (GERD), colorectal cancer, ulcerative colitis (UC), inflammatory bowel disease (IBD), and Crohn’s disease (CD) are being reported with increasing frequency. These changing trends present strong opportunities for medical device and healthcare companies to broaden their presence and operations within the Asian market.
While infectious diseases such as diarrhoeal illnesses, hepatitis, typhoid, and intestinal tuberculosis remain common in India, there is growing concern over the sharp rise in lifestyle-related gastrointestinal disorders. Disorders including irritable bowel syndrome, GERD, inflammatory bowel diseases like Crohn’s disease, non-alcoholic fatty liver disease, and cancers affecting the esophagus, colon, liver, pancreas, and gall bladder are becoming increasingly prevalent, signaling a major shift in the country’s gastrointestinal disease landscape.
